- Report
- November 2022
- 140 Pages
Europe
From €3080EUR$3,450USD£2,688GBP
- Report
- April 2023
- 160 Pages
Global
From €4418EUR$4,949USD£3,857GBP
- Report
- July 2024
- 156 Pages
Global
From €3794EUR$4,250USD£3,312GBP
- Report
- June 2022
- 300 Pages
Global
From €3214EUR$3,600USD£2,805GBP
- Report
- February 2024
- 94 Pages
Global
From €3500EUR$4,200USD£3,162GBP
- Report
- October 2023
- 98 Pages
Global
From €3500EUR$4,200USD£3,162GBP
- Report
- October 2023
- 109 Pages
Global
From €3500EUR$4,200USD£3,162GBP
- Report
- May 2022
- 103 Pages
Global
From €3500EUR$4,200USD£3,162GBP
- Report
- October 2023
- 146 Pages
Global
From €3705EUR$4,150USD£3,234GBP
Plasmapheresis is a process used in blood banking to separate plasma from whole blood. Plasma is the liquid component of blood that contains proteins, antibodies, and other substances. Plasmapheresis is used to collect plasma for transfusion, to treat certain medical conditions, and to manufacture therapeutic proteins.
The plasmapheresis market is driven by the increasing demand for plasma-derived products, such as immunoglobulins, albumin, and clotting factors. The rising prevalence of chronic diseases, such as hemophilia and thalassemia, is also driving the market. Additionally, the growing awareness of the therapeutic benefits of plasmapheresis is expected to fuel the market growth.
Some of the major companies in the plasmapheresis market include CSL Behring, Grifols, Octapharma, Kedrion, Biotest, and China Biologic Products. Show Less Read more